Company Proteo, Inc. Other OTC
Equities
PTEO
US74369R3084
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Oliver Wiedow
CEO | Chief Executive Officer | 66 | 00-11-30 |
Juergen Paal
COO | Chief Operating Officer | 53 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Oliver Wiedow
CEO | Chief Executive Officer | 66 | 00-11-30 |
Hartmut Weigelt
BRD | Director/Board Member | 74 | 00-11-30 |
Jork von Reden
BRD | Director/Board Member | 80 | 18-11-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 130,000 | 0 | 0 | 0.1502 % |
Stock B | 1 | 3,338 | 1,092 ( 32.71 %) | 0 | |
Stock C | 0 | 723,590 | 0 | 0 |
Company contact information
Proteo, Inc.
2102 Business Center Drive
92612, Irvine
+
Sector
1st Jan change | Capi. | |
---|---|---|
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |